Concepedia

Publication | Open Access

Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial

DOIFull Paper Access

161

Citations

17

References

2011

Year

Gareth J. Morgan, J. Anthony Child, Walter M. Gregory, Alex J. Szubert, Kim Cocks, Sue Bell, Nuria Navarro-Coy, Mark T. Drayson, Roger G. Owen, Sylvia Feyler,
The Lancet Oncology

Abstract

Medical Research Council (London, UK), Novartis, Schering Health Care, Chugai, Pharmion, Celgene, and Ortho Biotech.

References

YearCitations

Page 1